Table 2.
Female sex |
Bradycardia |
Hypokalaemia |
Heart failure |
Ventricular hypertrophy |
Recent cardioversion from atrial fibrillation |
High concentration of the drug with known, possible or conditional risk of TdP |
Baseline QTc prolongation |
Rapid rate of infusion of QTc-prolonging drug |
Subclinical long QTc syndrome |
Ion channel polymorphisms |
Severe hypomagnesaemia |